FGFlorent Wendinmi Bertrand Goumbri

Florent Wendinmi Bertrand Goumbri

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Florent Wendinmi Bertrand Goumbri has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • Boladé Constantin Atchade

    Laboratory for Drug Development (LADME), Center for Training, Research and Expertise in Drug Sciences (CEA-CFOREM), Doctoral School of Health Sciences (ED2S), Joseph KI-ZERBO University, BP-7021, Burkina Faso. Phytomedicine and Drug Research and Development Laboratory (LR-D/PM), Health Sciences Research Institute (IRSS), National Center for Scientific and Technological Research (CNRST) BP 7047 Ouagadougou 03, Burkina Faso

    2 shared publications
  • Rasmané Semdé

    Centre de Formation, de Recherche et d’Expertises en sciences du médicament (CEA-CFOREM), Université Joseph KI-ZERBO, Ouagadougou, Burkina Faso

    2 shared publications
  • Salfo Ouedraogo

    Research and Development Laboratory for Phytomedicines and Drugs (LR-D/PM), Institute for Research in Health Sciences (IRSS/CNRST), Ouagadougou, Burkina Faso; Laboratory of Drug Development (LADME), Joseph Ki-Zerbo University, Ouagadougou, Burkina Faso

    2 shared publications
  • Sylvin Ouedraogo

    Département Médecine et Pharmacopée Traditionnelles – Pharmacie (MEPHATRA-PH), Institut de Recherche en Sciences de la Santé/Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouagadougou, Burkina Faso

    2 shared publications
  • Tata Kadiatou Traore

    Research and Development Laboratory for Phytomedicines and Drugs (LR-D/PM), Institute for Research in Health Sciences (IRSS/CNRST), Ouagadougou, Burkina Faso

    2 shared publications
  • Traore Safiatou

    Research and Development Laboratory for Phytomedicines and Drugs (LR-D/PM), Institute for Research in Health Sciences (IRSS/CNRST), Ouagadougou, Burkina Faso; Laboratory of Drug Development (LADME), Joseph Ki-Zerbo University, Ouagadougou, Burkina Faso

    2 shared publications

Latest Publications

  • Open Access

    Development of Lozenges from Fruit Extract of Balanites aegyptiaca (L) Delile (Zygophyllaceae) for the Treatment of Occasional Constipation

    by Ouedraogo Salfo, Traore Kadiatou, Boly Laurent, Tapsoba Carine, Millogo Olivia, Atchade Constantin, Kabore Donacienne, Traore Safiatou, Goumbri Florent, Traore Aristide, et al.

    Balanites aegyptiaca (L.) Del. is a plant whose fruit pulp is traditionally used to treat constipation. They possess inherent laxative properties. This study aimed to improve upon the traditional method of use by developing lozenges with these laxative properties. An infusion was performed, and the physicochemical characteristics of the lyophilized extract were determined. The lozenges were formulated from the extract, and their quality and laxative efficacy in vivo were controlled in NMRI strain mice. The extract was yellow, had a bitter-sweet taste, a characteristic smell, and a fine texture. The pH was 5.56, and the RMC was 1.16%. The powder was highly hygroscopic, and the extraction yield was 33.71%, with a saponoside content of 2.76 μgED/mg. Fifteen (15) formulations were prepared, and formulation F7 was selected for the incorporation of the extract. The F7 was yellow, sweet, with an uncharacteristic odor and a hard appearance. The lozenges were uniform (1.95±0.04 g), with an average pH of 5.85±0.07 and a saponoside content of 2.01±0.26 μgED/mg. The lozenges had an accelerated intestinal transit percentage of 75.74±3.22%, comparable to that of the extract (78.10±4.32%) and castor oil (81.84±9.46%). After slowing down transit with loperamide (45.24±2.38%), the lozenges (60.84±7.13%) brought the percentage close to normal transit (65.94±3.33%). This study highlighted the laxative efficacy of lozenges made from Balanites aegyptiaca fruit pulp extract.

  • Open Access

    Formulation of Effervescent Granules Based on Calotropis procera Ait Powder (Apocynaceae) and Zanthoxylum zanthoxyloides Lam (Rutaceae)

    by Ouédraogo Salfo, Atchadé Constantin, Traoré Kadiatou, Rouamba Martin, Traoré Safiatou, Goumbri Florent, Yaméogo Josias, Ouédraogo Sylvin, Semdé Rasmané

    Introduction: Sickle cell disease is a genetic disease that affects nearly 5% of the world's population and is particularly prevalent in sub-Saharan Africa. The inaccessibility of modern treatment has led to the development of a phytomedicine called FACA® in Burkina Faso. It is formulated in capsule form and contains a mixture of powdered root barks of Zanthoxylum zanthoxyloides and Calotropis procera . This study aims to propose an alternative, easier-to-administer form for patients who have difficulty swallowing capsules by developing effervescent granules. Materials and methods: Pre-formulation studies focused on analyzing the physicochemical and pharmaco-technical properties of the powder mixture. These included macroscopic and organoleptic aspects, pH, residual moisture content, hygroscopicity, granulometry, and flow. Effervescent granules were formulated and manufactured by the wet granulation method. Five formulations (F1-F5) were produced. Citric acid and sodium bicarbonate were used as effervescent vehicles at a ratio of 1:1.25. PVP was used as a binding agent, sucrose as a sweetener, and cornstarch as a diluent. The granulation liquid was distilled water. The granules produced were evaluated for their physicochemical properties and disintegration time. Results and discussion: the results of the physicochemical and pharmaco-technical characteristics guided the choice of excipients and the manufacturing process. The formulations were beige in color and granular in appearance. THR values were <10%, pH ranged from 5.20 ± 0.29 to 5.91 ± 0.17. They were more or less hygroscopic and presented good rheological properties with an effervescence time satisfying the specifications of the European Pharmacopoeia 11th edition. Conclusion: F4 formulation had the best characteristics and could serve as an alternative to capsules. Indeed, being dispersed in water before administration, these granules could be well tolerated by the gastrointestinal tract and promote a more rapid action of the drug at a time of crisis.

  • Open Access

    Phytochemicals properties and antimicrobial activities of Carica papaya and Balanites aegyptiaca’ seeds aqueous infusion and decoction extracts

    by Assétou Ouedraogo, Philippe Augustin Nikiema, Marguerite Edith Malatala Nikiema, Josias Gérard Yameogo, Bernadette Pane Sourabie, Belinda Ramata Hafouo Bassave, Oueogo Nikiema, Florent Wendinmi Bertrand Goumbri, Nicolas Barro

    Carica papaya and Balanites aegyptiaca seeds extract have several uses, from food to traditional medicine. This study aims to determine their phytochemicals compound and appreciate their antimicrobial properties against clinical strains. Polyphenolic content was determined with standard methods while DPPH radical scavenging activity is used to appreciate the antioxidant properties, using ascorbic acid as standard. Antimicrobial activities were performed according to the inhibition diameters, using agar diffusion method. Minimum inhibitory concentrations and Minimum fungicidal concentrations were established based on broth dilution methods. The extraction yield is ranged between 6.3 and 20.3%. The results shown polyphenolic content varying from 1256.13±21.09 to 2315.81±53.52 µg GAE/100 mL for Carica papaya and from 303.98±0.93 to 948.06±3.23 µg GAE/100 mL for Balanites aegyptiaca while the antioxidant activity is ranged between 31.76±2.35 and 58.47±4.24 µg AEAC/100 mL for Carica papaya and from 29.80±0.32 to 78.44±2.81 µg AEAC/100 mL for Balanites aegyptiaca. Infusion’s extracts always have the highest values of polyphenols content and antioxidant activity than decoction extracts, be it papaya or balanites seeds. Neitheir flavonoids content nor antibacterial activity was found. The inhibition diameter varies from 14.5±0.5 to 40.5±0.5 mm for papaya seeds extracts and from 16.5±0.5 to 21.0±0.5 mm for balanites seeds extracts without a significative effect of mixture for both extracts. MICs vary from 11.71±0.1 to 75.0±0.0 mg. mL-1 for Carica papaya seeds extracts with 11.72±0.2 to 37.30±0.2 mg. mL-1 and 18.74±0.1 to 100±0.0 mg.mL-1 for Balanites aegyptiaca. Mixture extracts presented intermediaire values. Decoction extracts have lowest MICs values and infusion reveals itself to be the sweetable aqueous extraction techniques but the appropriate infusion time need to be highlight. Keywords: Carica papaya, Balanites aegyptiaca, Seeds extracts, Phytochemical, antifungal


  • African Shea Butter Properties Related to Common Extraction Technologies: A Review

    by Bertrand W. F. Goumbri, Thais Lomonaco Teodoro da Silva, Roland D. Marini, Rasmané Semdé, Touridomon Issa Somé, Sabine Danthine